| Variations in the natural history and survival of patients with supratentorial low-grade astrocytomas J Piepmeier, S Christopher, D Spencer, T Byrne, J Kim, JP Knisel, J Lacy, ... Neurosurgery 38 (5), 872-879, 1996 | 315 | 1996 |
| Integration of metabolomics and transcriptomics reveals major metabolic pathways and potential biomarker involved in prostate cancer S Ren, Y Shao, X Zhao, CS Hong, F Wang, X Lu, J Li, G Ye, M Yan, ... Molecular & Cellular Proteomics 15 (1), 154-163, 2016 | 170 | 2016 |
| Correlations between genomic subgroup and clinical features in a cohort of more than 3000 meningiomas MW Youngblood, D Duran, JD Montejo, C Li, SB Omay, K Özduman, ... Journal of neurosurgery 133 (5), 1345-1354, 2019 | 129 | 2019 |
| New developments in the pathogenesis and therapeutic targeting of the IDH1 mutation in glioma L Dimitrov, CS Hong, C Yang, Z Zhuang, JD Heiss International journal of medical sciences 12 (3), 201, 2015 | 127 | 2015 |
| LB100, a small molecule inhibitor of PP2A with potent chemo-and radio-sensitizing potential CS Hong, W Ho, C Zhang, C Yang, JB Elder, Z Zhuang Cancer biology & therapy 16 (6), 821-833, 2015 | 110 | 2015 |
| Laser-interstitial thermal therapy compared to craniotomy for treatment of radiation necrosis or recurrent tumor in brain metastases failing radiosurgery CS Hong, D Deng, A Vera, VL Chiang Journal of neuro-oncology 142, 309-317, 2019 | 109 | 2019 |
| Impairment of glioma stem cell survival and growth by a novel inhibitor for survivin–ran protein complex H Guvenc, MS Pavlyukov, K Joshi, H Kurt, YK Banasavadi-Siddegowda, ... Clinical Cancer Research 19 (3), 631-642, 2013 | 109 | 2013 |
| Activation of hypoxia signaling induces phenotypic transformation of glioma cells: implications for bevacizumab antiangiogenic therapy H Xu, S Rahimpour, CL Nesvick, X Zhang, J Ma, M Zhang, G Zhang, ... Oncotarget 6 (14), 11882, 2015 | 87 | 2015 |
| Maternal embryonic leucine zipper kinase: key kinase for stem cell phenotype in glioma and other cancers R Ganguly, CS Hong, LGF Smith, HI Kornblum, I Nakano Molecular cancer therapeutics 13 (6), 1393-1398, 2014 | 86 | 2014 |
| Low-grade gliomas of chronic epilepsy: a distinct clinical and pathological entity JC Bartolomei, S Christopher, K Vives, DD Spencer, JM Piepmeier Journal of neuro-oncology 34, 79-84, 1997 | 82 | 1997 |
| Long-term results of a randomized phase III trial of TPF induction chemotherapy followed by surgery and radiation in locally advanced oral squamous cell carcinoma L Zhong, C Zhang, G Ren, W Guo, WN William Jr, CS Hong, J Sun, H Zhu, ... Oncotarget 6 (21), 18707, 2015 | 74 | 2015 |
| Comparison of endoscope-versus microscope-assisted resection of deep-seated intracranial lesions using a minimally invasive port retractor system CS Hong, DM Prevedello, JB Elder Journal Of Neurosurgery 124 (3), 799-810, 2016 | 69 | 2016 |
| Inhibition of protein phosphatase 2A with a small molecule LB100 radiosensitizes nasopharyngeal carcinoma xenografts by inducing mitotic catastrophe and blocking DNA damage repair P Lv, Y Wang, J Ma, Z Wang, JL Li, CS Hong, Z Zhuang, YX Zeng Oncotarget 5 (17), 7512, 2014 | 65 | 2014 |
| Metabolomics study of roux-en-Y gastric bypass surgery (RYGB) to treat type 2 diabetes patients based on ultraperformance liquid chromatography–mass spectrometry P Luo, H Yu, X Zhao, Y Bao, CS Hong, P Zhang, Y Tu, P Yin, P Gao, L Wei, ... Journal of proteome research 15 (4), 1288-1299, 2016 | 57 | 2016 |
| Protein phosphatase 2A inhibition with LB100 enhances radiation-induced mitotic catastrophe and tumor growth delay in glioblastoma IK Gordon, J Lu, CA Graves, K Huntoon, JM Frerich, RH Hanson, X Wang, ... Molecular cancer therapeutics 14 (7), 1540-1547, 2015 | 57 | 2015 |
| Intervention for a randomized trial of unruptured brain arteriovenous malformations (ARUBA)—eligible patients: an evidence-based review CS Hong, EC Peterson, D Ding, S Sur, D Hasan, AS Dumont, N Chalouhi, ... Clinical neurology and neurosurgery 150, 133-138, 2016 | 52 | 2016 |
| Comparison of epidemiology, treatments, and outcomes in pediatric versus adult ependymoma AA Elsamadicy, AB Koo, WB David, V Lee, CK Zogg, AJ Kundishora, ... Neuro-oncology advances 2 (1), vdaa019, 2020 | 45 | 2020 |
| TERT promoter mutations contribute to IDH mutations in predicting differential responses to adjuvant therapies in WHO grade II and III diffuse gliomas ZY Zhang, AKY Chan, XJ Ding, ZY Qin, CS Hong, LC Chen, X Zhang, ... Oncotarget 6 (28), 24871, 2015 | 42 | 2015 |
| Multi-kinase inhibitor C1 triggers mitotic catastrophe of glioma stem cells mainly through MELK kinase inhibition M Minata, C Gu, K Joshi, M Nakano-Okuno, C Hong, CH Nguyen, ... PloS one 9 (4), e92546, 2014 | 42 | 2014 |
| Laser interstitial thermal therapy (LITT) vs. bevacizumab for radiation necrosis in previously irradiated brain metastases N Sujijantarat, CS Hong, KA Owusu, AA Elsamadicy, JP Antonios, AB Koo, ... Journal of Neuro-Oncology 148, 641-649, 2020 | 38 | 2020 |
